You are here:

NICE
NICE Guidance
Conditions and diseases
Cardiovascular conditions
Lipid disorders

Evolocumab for treating primary hypercholesterolaemia and mixed dyslipidaemia

Technology appraisal guidance
Reference number: TA394
Published: 22 June 2016

Guidance
Tools and resources
Information for the public
Evidence
History

On this page

Implementation support
Guidance into practice

Tools and resources

Tools to help you put the guidance into practice.

Implementation support

NHS England summary of national guidance for lipid management
NHS England statin intolerance pathway
Measuring the use of NICE guidance

Guidance into practice

About the Into practice guide
Practical steps to improving the quality of care and services using NICE guidance